DimakakosELivaniosKGkiozosIet al.
New data for venous thromboembolism in patients with small cell lung cancer: a review.Phlebology2018;
33: 517–522
2.
SallaEDimakakosEPTsagkouliSet al.
Venous thromboembolism in patients diagnosed with lung cancer.Angiology2016;
67: 709–724.
3.
MansfieldASTafurAJWangCEet al.
Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer.J Thromb Haemost2016;
14: 1773–1778.
4.
PoschFRiedlJReitterEMet al.
Hypercoagulabilty, venous thromboembolism, and death in patients with cancer. A multi-state model.Thromb Haemost2016;
115: 817–826.
5.
KudererNMCulakovaELymanGHet al.
A validated risk score for venous thromboembolism is predictive of cancer progression and mortality.Oncologist2016;
21: 861–867.
6.
VathiotisIDimakakosEPBouraPet al.
Khorana score: new predictor of early mortality in patients with lung adenocarcinoma.Clin Appl Thromb Hemost2018;
24: 1347–1351.
